• Ticker:- PPH;false;MVPPH;
  • Ticker Group:- ETFEQ_IND;false;;
  • How to Purchase

Individual Investors

Subscribe to email updates

Subscribe now

Financial Professionals

Subscribe to email updates, or password protected financial professional-only content
email address/username
password

Pharmaceutical ETF PPH

  • Full Name: Market Vectors®
    Pharmaceutical ETF (PPH)

    Management Style: Replication

    Underlying Index: Market Vectors US Listed Pharmaceutical 25 Index (MVPPHTR)

    Index Provider: Market Vectors Index Solutions

    Index Description: MVPPHTR is a rules-based index intended to track the overall performance of 25 of the largest U.S. listed, publicly traded pharmaceutical companies.

  •  
      

    • Fund Ticker

      PPH
    • Exchange

      NYSE Arca
    • Commencement

      12/20/2011
    • ETF Structure

      Physical
    • Administrator

      Van Eck Associates
    • Custodian

      Bank of New York Mellon
    • Index Ticker

      MVPPHTR
    • Index Rebalancing

      Quarterly
  •  
    as of 10/22/14

    • 30-Day SEC Yield1

      1.98%
    • Total Net Assets

      $366.7M
    • Number of Holdings

      27
    • Options

      Available
    • Gross Expense Ratio2

      0.43%
    • Net Expense Ratio/TER2

      0.35%
    • Distribution Frequency

      Quarterly
    • Next Distribution Date

      12/26/2014
  • Portfolio Composition (%)
    as of 10/22/14

    • % of Net Assets
    • Stocks

      100.08
    • Bonds

      0.00
    • Other

      0.00
    • Cash

      -0.08
  • Download All HoldingsAll Holdings (%)as of 10/22/14

    Total Holdings: 26
    Holding Name
    Ticker
    SharesMarket Value
    (US$)
    % of Net
    Assets
    Johnson & Johnson
    JNJ US
    397,206
    40,205,19110.97
    Novartis Ag
    NVS US
    406,829
    35,882,3189.79
    Pfizer Inc
    PFE US
    943,203
    26,692,6457.28
    Merck & Co Inc
    MRK US
    374,311
    20,778,0045.67
    Sanofi
    SNY US
    381,149
    20,059,8725.47
    Novo Nordisk A/S
    NVO US
    412,793
    18,716,0355.10
    Glaxosmithkline Plc
    GSK US
    401,183
    17,816,5374.86
    Bristol-Myers Squibb Co
    BMY US
    334,201
    17,324,9804.73
    Abbvie Inc
    ABBV US
    298,495
    16,984,3664.63
    Actavis Plc
    ACT US
    72,229
    16,714,5134.56
    Abbott Laboratories
    ABT US
    397,929
    16,549,8674.51
    Eli Lilly & Co
    LLY US
    255,086
    16,498,9624.50
    Allergan Inc/United States
    AGN US
    86,054
    15,731,5324.29
    Astrazeneca Plc
    AZN US
    228,531
    15,718,3624.29
    Teva Pharmaceutical Industries Ltd
    TEVA US
    258,131
    13,735,1513.75
    Valeant Pharmaceuticals International I
    VRX US
    90,100
    11,602,1773.16
    Mckesson Corp
    MCK US
    58,830
    11,505,3833.14
    Shire Plc
    SHPG US
    58,769
    10,859,9242.96
    Perrigo Co
    PRGO US
    34,856
    5,237,4631.43
    Mylan Inc/Pa
    MYL US
    103,441
    5,209,2891.42
    Zoetis Inc
    ZTS US
    132,152
    4,742,9351.29
    Mallinckrodt Plc
    MNK US
    30,346
    2,643,1370.72
    Endo Pharmaceuticals Holdings Inc
    ENDP US
    34,045
    2,151,3040.59
    Hospira Inc
    HSP US
    40,151
    2,010,7620.55
    Salix Pharmaceuticals Ltd
    SLXP US
    11,671
    1,606,0460.44
    Other/Cash
    -311,506-0.08
    These are not recommendations to buy or to sell any security. Securities and holdings may vary.